Clinical studies have shown that IL-8 is consistently highly expressed in PDAC patients and its upregulation in pancreatic cancers is associated with increased metastatic potential and overall dismal prognosis14–18. The gene discussed is CXCL8; the disease is familial pancreatic carcinoma.